Cargando…

Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy

The false negative rate of the diagnostic RT-PCR test for SARS-CoV-2 has been reported to be substantially high. Due to limited availability of testing, only a non-random subset of the population can get tested. Hence, the reported test counts are subject to a large degree of selection bias. We cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhaduri, Ritwik, Kundu, Ritoban, Purkayastha, Soumik, Kleinsasser, Michael, Beesley, Lauren J., Mukherjee, Bhramar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523173/
https://www.ncbi.nlm.nih.gov/pubmed/32995829
http://dx.doi.org/10.1101/2020.09.24.20200238
_version_ 1783588338151718912
author Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
author_facet Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
author_sort Bhaduri, Ritwik
collection PubMed
description The false negative rate of the diagnostic RT-PCR test for SARS-CoV-2 has been reported to be substantially high. Due to limited availability of testing, only a non-random subset of the population can get tested. Hence, the reported test counts are subject to a large degree of selection bias. We consider an extension of the Susceptible-Exposed-Infected-Removed (SEIR) model under both selection bias and misclassification. We derive closed form expression for the basic reproduction number under such data anomalies using the next generation matrix method. We conduct extensive simulation studies to quantify the effect of misclassification and selection on the resultant estimation and prediction of future case counts. Finally we apply the methods to reported case-death-recovery count data from India, a nation with more than 5 million cases reported over the last seven months. We show that correcting for misclassification and selection can lead to more accurate prediction of case-counts (and death counts) using the observed data as a beta tester. The model also provides an estimate of undetected infections and thus an undereporting factor. For India, the estimated underreporting factor for cases is around 21 and for deaths is around 6. We develop an R-package SEIR-fansy for broader dissemination of the methods.
format Online
Article
Text
id pubmed-7523173
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-75231732020-09-30 Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy Bhaduri, Ritwik Kundu, Ritoban Purkayastha, Soumik Kleinsasser, Michael Beesley, Lauren J. Mukherjee, Bhramar medRxiv Article The false negative rate of the diagnostic RT-PCR test for SARS-CoV-2 has been reported to be substantially high. Due to limited availability of testing, only a non-random subset of the population can get tested. Hence, the reported test counts are subject to a large degree of selection bias. We consider an extension of the Susceptible-Exposed-Infected-Removed (SEIR) model under both selection bias and misclassification. We derive closed form expression for the basic reproduction number under such data anomalies using the next generation matrix method. We conduct extensive simulation studies to quantify the effect of misclassification and selection on the resultant estimation and prediction of future case counts. Finally we apply the methods to reported case-death-recovery count data from India, a nation with more than 5 million cases reported over the last seven months. We show that correcting for misclassification and selection can lead to more accurate prediction of case-counts (and death counts) using the observed data as a beta tester. The model also provides an estimate of undetected infections and thus an undereporting factor. For India, the estimated underreporting factor for cases is around 21 and for deaths is around 6. We develop an R-package SEIR-fansy for broader dissemination of the methods. Cold Spring Harbor Laboratory 2020-09-25 /pmc/articles/PMC7523173/ /pubmed/32995829 http://dx.doi.org/10.1101/2020.09.24.20200238 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/It is made available under a CC-BY 4.0 International license (http://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Article
Bhaduri, Ritwik
Kundu, Ritoban
Purkayastha, Soumik
Kleinsasser, Michael
Beesley, Lauren J.
Mukherjee, Bhramar
Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title_full Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title_fullStr Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title_full_unstemmed Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title_short Extending the Susceptible-Exposed-Infected-Removed (SEIR) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy
title_sort extending the susceptible-exposed-infected-removed (seir) model to handle the high false negative rate and symptom-based administration of covid-19 diagnostic tests: seir-fansy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523173/
https://www.ncbi.nlm.nih.gov/pubmed/32995829
http://dx.doi.org/10.1101/2020.09.24.20200238
work_keys_str_mv AT bhaduriritwik extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT kunduritoban extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT purkayasthasoumik extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT kleinsassermichael extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT beesleylaurenj extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy
AT mukherjeebhramar extendingthesusceptibleexposedinfectedremovedseirmodeltohandlethehighfalsenegativerateandsymptombasedadministrationofcovid19diagnostictestsseirfansy